Characterization of the prostanoid receptor profile of enprostil and isomers in smooth muscle and platelets in vitro
暂无分享,去创建一个
[1] R. Eglen,et al. RS‐61756‐007: a potent and selective thromboxane receptor (TP) agonist , 1989, The Journal of pharmacy and pharmacology.
[2] A. Robertson,et al. The classification of prostaglandin DP‐receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist , 1989, British journal of pharmacology.
[3] M. Wasserman,et al. Effects of putative thromboxane receptor agonists and antagonists on rat small intestinal ion transport. , 1988, Journal of Pharmacology and Experimental Therapeutics.
[4] R. Eglen,et al. The action of prostanoid receptor agonists and antagonists on smooth muscle and platelets , 1988, British journal of pharmacology.
[5] M. Beinborn,et al. Enrichment and characterization of specific [3H]PGE2 binding sites in the porcine gastric mucosa. , 1988, European journal of pharmacology.
[6] J. Esplugues,et al. Close-arterial administration of the thromboxane mimetic U-46619 induces damage to the rat gastric mucosa. , 1988, Prostaglandins.
[7] K. Bunce,et al. Mechanism of stimulation of colonic secretion in the rat by the prostanoid enprostil , 1988 .
[8] J. J. Reeves,et al. Thromboxane receptors can modulate gastric acid secretion in the rat. , 1987, Prostaglandins.
[9] J. Rask-Madsen,et al. Enprostil and ranitidine in prevention of duodenal ulcer relapse: one year double blind comparative trial. , 1987, British medical journal.
[10] R. A. Coleman. Methods in prostanoid receptor classification , 1987 .
[11] Á. Guzmán,et al. Synthesis and gastric antisecretory properties of allenic 16-phenoxy-omega-tetranor prostaglandin E analogs. , 1987, Prostaglandins.
[12] P. Collins,et al. Chapter 19 Agents for the Treatment of Peptic Ulcer Disease , 1987 .
[13] A. Roszkowski,et al. Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17,18,19,20-tetranor-9-oxoprosta- 4,5,13(t)-trienoic acid methyl ester. , 1986, Journal of Pharmacology and Experimental Therapeutics.
[14] G. Crean,et al. Effect of a single oral dose of enprostil on gastric secretion and gastrin release. Studies in healthy volunteers and patients with pernicious anemia. , 1986, American Journal of Medicine.
[15] J. Isenberg,et al. Enprostil, a synthetic prostaglandin E2 analogue, inhibits meal-stimulated gastric acid secretion and gastrin release in patients with duodenal ulcer. , 1986, The American journal of medicine.
[16] R. Álvarez,et al. Prostanoid inhibition of canine parietal cells. , 1986, The American journal of medicine.
[17] B. Whittle,et al. Prostaglandin D2 interacts at thromboxane receptor‐sites on guinea‐pig platelets , 1986, British journal of pharmacology.
[18] L. Waterbury,et al. Gastric mucosal binding studies with enprostil: a potent anti-ulcer prostaglandin. , 1986, Prostaglandins.
[19] R. Robertson. Characterization and regulation of prostaglandin and leukotriene receptors: an overview. , 1986, Prostaglandins.
[20] Yang Dong,et al. Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues , 1986, British journal of pharmacology.
[21] J. J. Reeves,et al. Effects of indomethacin, piroxicam and selected prostanoids on gastric acid secretion by the rat isolated gastric mucosa , 1985, British journal of pharmacology.
[22] R. Gorman,et al. Cytoprotective and antisecretory properties of a non-diarrheogenic and non-uterotonic prostacyclin analog: U-68,215. , 1985, Prostaglandins.
[23] M. Beinborn,et al. Binding of 3H-iloprost to rat gastric mucosa: a pitfall in performing radioligand binding assays. , 1985, Research communications in chemical pathology and pharmacology.
[24] B. Whittle,et al. Interaction of prostaglandin D2 with prostacyclin, carbacyclin and the hydantoin prostaglandin, BW245C, in guinea‐pig platelets , 1985, British journal of pharmacology.
[25] D. Wilson,et al. Effects of prostaglandin E2, 16,16-dimethyl prostaglandin E2 and a prostaglandin endoperoxide analogue (U-46619) on gastric secretory volume, [H+] and mucus synthesis and secretion in the rat. , 1984, Prostaglandins.
[26] R. A. Coleman,et al. Studies on the characterisation of prostanoid receptors: a proposed classification. , 1982, Prostaglandins.
[27] R. A. Coleman,et al. COMPARISON OF THE ACTIONS OF U‐46619, A PROSTAGLANDIN H2‐ANALOGUE, WITH THOSE OF PROSTAGLANDIN H2 AND THROMBOXANE A2 ON SOME ISOLATED SMOOTH MUSCLE PREPARATIONS , 1981, British journal of pharmacology.
[28] J. Emmerson,et al. The zig‐zag tracheal strip , 1979, The Journal of pharmacy and pharmacology.
[29] P. Hedqvist,et al. Prostaglandin-induced neurotransmission failure in the field-stimulated, isolated vas deferens. , 1972, Neuropharmacology.
[30] R. Furchgott. The Classification of Adrenoceptors (Adrenergic Receptors). An Evaluation from the Standpoint of Receptor Theory , 1972 .
[31] R. B. Parker,et al. Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. I. Agonists. , 1971, The Journal of pharmacology and experimental therapeutics.